Concert Pharma (CNCE) Tops Q1 EPS by 39c

Concert Pharma (NASDAQ: CNCE) reported Q1 EPS of ($0.19), $0.39 better than the analyst estimate of ($0.58). Revenue for the quarter came in at $10.5 thousand versus the consensus estimate of $10 thousand.

For earnings history and earnings-related data on Concert Pharma (CNCE) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Movano (MOVE) Misses Q2 EPS by 195c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c